Correlation of pathogenic POLE mutations with clinical benefit to immune checkpo
- This topic has 0 replies, 1 voice, and was last updated 4 years, 2 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Correlation of pathogenic POLE mutations with clinical benefit to immune checkpoint inhibitor therapy.
https://meetinglibrary.asco.org/record/186715/abstract
Viewing 1 post (of 1 total)
- The forum ‘New Developments’ is closed to new topics and replies.